Singulex Singulex's Troponin Assay Gets CE Marking The test is the first offered for the Sgx Clarity system, a fully automated in vitro diagnostic platform leveraging single-molecule counting technology. Singulex Closes $50M Debt Facility Singulex plans to use the investment to continue to develop its single-molecule counting technology. Singulex Receives CE Mark for Sgx Clarity System The firm also plans to list its cardiac troponin I assay as CE marked and plans to submit data to the FDA for clearance of its Clarity system and assay in 2018. Singulex Expands Clinical Evaluation of Sgx Clarity System in Europe The automated immunodiagnostics system is based on Singulex's single molecule counting technology. Singulex to Seek FDA Clearance for Sgx Clarity; Aims for Point-of-Care Prototype by Year End Premium Singulex's CEO provided an update at the JP Morgan Healthcare conference on the firm's progress in developing its immunodiagnostics platform. Dec 8, 2016 Singulex Will Use Thermo Fisher Scientific Dx License to Develop Next-Gen Immunodiagnostics May 25, 2016 Singulex Readies Immunodiagnostics System for CE Mark Validation in Europe, Clinical Studies in US Premium May 18, 2016 Grifols Takes 20 Percent Stake in Singulex Jan 15, 2016 JP Morgan Healthcare Conference Day Four: Luminex, Exact Sciences, T2 Biosystems, Singulex May 21, 2015 EMD Millipore Acquires Rights to Singulex's Life Science Research Business Apr 30, 2015 Singulex, Dutch Technology Foundation Partner on Center for Biomarker Development Apr 9, 2015 Singulex, CHDI Collaborate on Biomarkers for Huntington's Disease May 30, 2014 People in the News: Peter Heseltine, Mark Emberton Premium Mar 31, 2014 Sony DADC to Develop Detection Vessels for Singulex's IVD Platform Nov 1, 2013 People in the News: Chee Gee See, Jeffrey Bishop, Linda Greub Premium Sep 26, 2013 Single Molecule Counting Tech Firm Singulex Secures $55M in Financing May 31, 2013 People in the News: A New CEO at Singulex Premium Nov 2, 2012 Plasmonic ELISA Offers High-Sensitivity Protein Assay Readable by the Naked Eye Premium Jun 8, 2012 New 'Inverse Sensitivity' Nanosensor Generates Highest Signal at Lowest Protein Concentrations Premium May 4, 2012 New Products: Singulex's IL-17A/F Assay Premium Apr 13, 2012 Somalogic Teams with HUNT for 2,000-Patient Validation Study of Cardiovascular Biomarkers Premium Mar 16, 2012 Wash U Study Shows VILIP-1 a Potential Biomarker for Predicting Alzheimer's Progression Premium Mar 25, 2011 JAMA Study Bolsters Case for High-Sensitivity Troponin Diagnostics Premium Dec 17, 2010 Singulex Receives US Patent for Cardiovascular Biomarker Assay, Begins Planning FDA Submission Premium Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.